PCI Biotech first half 2023 interim results
31 août 2023 01h00 HE
|
PCI Biotech Holding ASA
Oslo (Norway), 31 August 2023 – PCI Biotech (OSE: PCIB), today announces its interim first half 2023 results. Please find enclosed the report and presentation.Highlights review fimaNAc –...
PCI Biotech: Invitation to first half interim 2023 results presentation
25 août 2023 08h30 HE
|
PCI Biotech Holding ASA
Oslo, Norway, 25 August 2023 - PCI Biotech (OSE: PCIB) invites to a webcast presentation of the company's first half 2023 interim report on Thursday 31 August 2023, 08:30am – 09:30am CEST (local...
Minutes from Annual General Meeting 2023
25 mai 2023 05h38 HE
|
PCI Biotech Holding ASA
Oslo, 25 May 2023. The Annual General Meeting in PCI Biotech Holding ASA took place today, 25 May 2023. All the matters on the agenda were approved and the minutes of the Annual General Meeting are...
Disclosure of voting rights for Chairman of the Board
24 mai 2023 04h43 HE
|
PCI Biotech Holding ASA
Oslo, 24 May 2023. PCI Biotech Holding ASA ("PCI Biotech" or the "Company") issue this notification on behalf of its chairman, Hans Peter Bøhn. Hans Peter Bøhn is chairman of PCI Biotech and shall...
PCI Biotech interim Q1 2023 results
12 mai 2023 01h00 HE
|
PCI Biotech Holding ASA
Oslo (Norway), 12 May 2023 – PCI Biotech (OSE: PCIB), today announces its interim Q1 2023 results. Please find enclosed the report and presentation. Highlights reviewfimaNAc – bioprocessingThe...
PCI Biotech: Invitation to Q1 2023 results presentation
09 mai 2023 09h52 HE
|
PCI Biotech Holding ASA
Oslo, Norway, 9 May 2023 - PCI Biotech (OSE: PCIB) invites to a webcast presentation of the company's Q1 2023 interim report on Friday 12 May 2023, 08:30am – 09:30am CEST (local time). The...
PCI Biotech - Notice of Annual General Meeting 2023
04 mai 2023 04h04 HE
|
PCI Biotech Holding ASA
Oslo, Norway 4 May 2023 - The annual general meeting of PCI Biotech Holding ASA will be held at the company’s office at Oslo Cancer Cluster Innovation Park, on 25 May 2023 at 10:00am (CEST). The...
PCI Biotech Holding ASA: Annual Report 2022
28 avr. 2023 03h59 HE
|
PCI Biotech Holding ASA
Oslo, Norway, April 28, 2023The Board of Directors of PCI Biotech Holding ASA has approved the Annual Report 2022. Please find the report attached, as well as the report according to the European...
PCI Biotech interim Q4 2022 results
17 févr. 2023 01h00 HE
|
PCI Biotech Holding ASA
Oslo (Norway), 17 February 2023 – PCI Biotech (OSE: PCIB), today announces its interim Q4 2022 results. Please find enclosed the report and presentation. Highlights fimaNAc – dermatology and...
PCI Biotech: Invitation to Q4 2022 results presentation
13 févr. 2023 09h35 HE
|
PCI Biotech Holding ASA
Oslo, Norway, 13 February 2023 - PCI Biotech (OSE: PCIB) invites to an online presentation of the company's Q4 2022 interim report on Friday 17 February 2023, 08:30am – 09:30am CET (local time). The...